GEHC 📈 GE HealthCare Technologies - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US36266G1076

GEHC: Imaging Machines, Ultrasound Devices, Patient Monitoring Systems, Diagnostic Agents

GE HealthCare Technologies Inc. is a leading developer, manufacturer, and marketer of medical products, services, and digital solutions that cater to the diagnosis, treatment, and monitoring of patients globally. The company's operations are divided into four distinct segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. Each segment offers a unique set of products and services that cater to specific needs in the healthcare industry. For instance, the Imaging segment provides a range of products, including molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, and X-ray systems, which are essential for accurate diagnoses and treatments. Additionally, this segment also offers image-guided therapy and women's health products, which are critical in providing comprehensive care to patients.

The Ultrasound segment is another vital part of GE HealthCare Technologies Inc., providing medical devices and solutions for various clinical areas, such as radiology, primary care, women's health, and cardiovascular care. The segment's products include point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products, which enable healthcare professionals to make informed decisions and provide effective care. The Patient Care Solutions segment, on the other hand, offers a broad portfolio of medical devices, consumables, services, and digital solutions, including patient monitoring solutions, anesthesia delivery and respiratory care products, and maternal infant care products. This segment's products and services are designed to support healthcare professionals in providing high-quality patient care.

The Pharmaceutical Diagnostics segment supplies diagnostic agents, including contrast media pharmaceuticals and molecular imaging agents, to the radiology and nuclear medicine industry. These agents are used to increase the visibility of tissues or structures during imaging exams, enabling healthcare professionals to make accurate diagnoses and develop effective treatment plans. Furthermore, the company has collaborated with Mass General Brigham to leverage artificial intelligence (AI) in its operations, which is expected to enhance its product offerings and services. With its headquarters in Chicago, Illinois, and a global presence, GE HealthCare Technologies Inc. is well-positioned to drive innovation and growth in the healthcare industry.

As a publicly traded company, GE HealthCare Technologies Inc. is committed to delivering value to its shareholders while providing innovative solutions to the healthcare industry. The company's common stock is listed on the NASDAQ stock exchange, and its operations are guided by a strong commitment to quality, innovation, and customer satisfaction. With a web presence at https://www.gehealthcare.com, the company provides easy access to information about its products, services, and operations, making it a transparent and accountable player in the healthcare industry. The company's ISIN, US36266G1076, and GICS Sub Industry classification as Health Care Equipment, further underscore its focus on providing specialized equipment and solutions to the healthcare sector.

Additional Sources for GEHC Stock

GEHC Stock Overview

Market Cap in USD 39,410m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Equipment
IPO / Inception 2023-01-04

GEHC Stock Ratings

Growth 5y 54.4%
Fundamental 55.6%
Dividend 38.0%
Rel. Strength Industry 1717
Analysts 4.05/5
Fair Price Momentum 76.43 USD
Fair Price DCF 95.98 USD

GEHC Dividends

Dividend Yield 12m 0.11%
Yield on Cost 5y 0.15%
Annual Growth 5y 15.47%
Payout Consistency 100.0%

GEHC Growth Ratios

Growth Correlation 3m -84.5%
Growth Correlation 12m 9.9%
Growth Correlation 5y 61%
CAGR 5y 18.34%
CAGR/Mean DD 5y 1.71
Sharpe Ratio 12m 0.36
Alpha -9.76
Beta 0.88
Volatility 30.28%
Current Volume 3792.2k
Average Volume 20d 3226.6k
What is the price of GEHC stocks?
As of January 12, 2025, the stock is trading at USD 84.76 with a total of 3,792,183 shares traded.
Over the past week, the price has changed by +5.27%, over one month by +2.91%, over three months by -6.05% and over the past year by +11.44%.
Is GE HealthCare Technologies a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, GE HealthCare Technologies (NASDAQ:GEHC) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 55.60 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GEHC as of January 2025 is 76.43. This means that GEHC is currently overvalued and has a potential downside of -9.83%.
Is GEHC a buy, sell or hold?
GE HealthCare Technologies has received a consensus analysts rating of 4.05. Therefor, it is recommend to buy GEHC.
  • Strong Buy: 10
  • Buy: 3
  • Hold: 6
  • Sell: 0
  • Strong Sell: 1
What are the forecast for GEHC stock price target?
According to ValueRays Forecast Model, GEHC GE HealthCare Technologies will be worth about 83.8 in January 2026. The stock is currently trading at 84.76. This means that the stock has a potential downside of -1.18%.
Issuer Forecast Upside
Wallstreet Target Price 96.8 14.2%
Analysts Target Price 96.3 13.7%
ValueRay Target Price 83.8 -1.2%